Cancer

AUG 13, 2026 · JOURNAL ARTICLE

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia

Cancer

Retrospective cohort analysis identifying prognostic factors and comparing outcomes across therapies in NPM1-mutated AML, with clear survival endpoints but limited by single-center design and observational methodology.

AUG 10, 2026 · JOURNAL ARTICLE

How low do you need to go? Association between various prostate‐specific antigen response measures and clinical outcomes in metastatic castration‐sensitive prostate cancer in the Veterans Health Administration data

Cancer

Large real-world retrospective cohort with 4890 patients, adjusted Cox regression analysis, and hard clinical endpoint (overall survival), demonstrating that PSA nadir <0.2 ng/mL predicts OS benefit independent of percentage decline.

AUG 7, 2026 · JOURNAL ARTICLE

Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor–positive and triple‐negative breast cancer patients

Cancer

Population-based cohort study with adequate sample size showing protective mortality effects in HR+ breast cancer with post-diagnostic bisphosphonates, but observational design, lack of randomization, and conflicting results in TNBC subgroup limit strength.